Company Filing History:
Years Active: 2006-2021
Title: Akihisa Sakamoto: Innovator in Therapeutic Agents
Introduction
Akihisa Sakamoto is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of therapeutic agents, holding two patents that showcase his innovative approach to medical science.
Latest Patents
Sakamoto's latest patents include a cytotoxicity-inducing therapeutic agent. This invention involves replacing the antigen-binding domain to discover novel polypeptide complexes that maintain BiTE's strong anti-tumor activity and excellent safety properties. These complexes also exhibit a long half-life in blood and can damage various target cells. Another patent focuses on peptide derivatives, specifically a compound of Formula (1), which involves a complex between factor VIIa and human soluble tissue factor, along with a low-molecular weight reversible factor VIIa inhibitor. This patent also includes a method for computationally designing such inhibitors using coordinate data obtained from X-ray crystal structure analysis.
Career Highlights
Sakamoto is currently associated with Chugai Seiyaku Kabushiki Kaisha, a prominent company in the pharmaceutical industry. His work there emphasizes the development of innovative therapeutic solutions that address critical health challenges.
Collaborations
He has collaborated with notable coworkers, including Junichi Nezu and Takahiro Ishiguro, contributing to the advancement of their shared research goals.
Conclusion
Akihisa Sakamoto's work exemplifies the spirit of innovation in the medical field, particularly through his patents that aim to improve therapeutic agents. His contributions are significant in the ongoing quest for effective treatments.